BASILEA PHARMACEUTICA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.9 CHF | -1.35% |
|
+2.45% | +24.36% |
| 05-03 | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
| 04-09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Basilea Pharmaceutica AG
| 2013-04-10 | Annual 5 CHF |
- Stock Market
- Equities
- BSLN Stock
- Charts Basilea Pharmaceutica AG
- Total Return chart